Dart Therapeutics: Backed By Non-Profits, Open To Venture
This article was originally published in Start Up
Executive Summary
Dart Therapeutics is owned and funded by rare disease patient foundations, and tiny ones at that. But with its first candidate, for Duchenne muscular dystrophy, it has created a special ownership structure to move the program forward. That takes a page from the recent private investor playbook, and Dart’s CEO wants to use venture capital to fund more programs without losing its patient-centric vision and grassroots passion.